Glomerular Cell Biology

Seldin and Geibisch's The Kidney

Volumn 1, Issue , 2013, Pages 721-755

  Maezawa, Yoshiro ^a   Cina, Davide ^a,b   Quaggin, Susan E ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b Institute of Medical Science   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884007063     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381462-3.00022-7     Document Type: Chapter

References (326)

1. Abrahamson D.R. Origin of the glomerular basement membrane visualized after in vivo labeling of laminin in newborn rat kidneys. J Cell Biol 1985, 100(6):1988-2000.
2. Abrahamson D.R. Structure and development of the glomerular capillary wall and basement membrane. Am J Physiol 1987, 253(5 Pt 2):F783-94.
3. Abrahamson D.R., Hudson B.G., Stroganova L., Borza D.-B.St, John P.L. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol 2009, 20(7):1471-1479.
4. Akilesh S., Suleiman H., Yu H., Stander M.C., Lavin P., Gbadegesin R., et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest 2011, 121(10):4127-4137.
5. Andres A.-C., Munarini N., Djonov V., Bruneau S., Zuercher G., Loercher S., et al. EphB4 receptor tyrosine kinase transgenic mice develop glomerulopathies reminiscent of aglomerular vascular shunts. Mech Dev 2003, 120(4):511-516.
6. Appel D., Kershaw D.B., Smeets B., Yuan G., Fuss A., Frye B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009, 20(2):333-343.
7. Ara T., Tokoyoda K., Okamoto R., Koni P.A., Nagasawa T. The role of CXCL12 in the organ-specific process of artery formation. Blood 2005, 105(8):3155-3161.
8. Ardaillou N., Blaise V., Costenbader K., Vassitch Y., Ardaillou R. Characterization of a B2-bradykinin receptor in human glomerular podocytes. Am J Physiol 1996, 271(3 Pt 2):F754-61.
9. Arrondel C., Vodovar N., Knebelmann B., Grünfeld J.-P., Gubler M.-C., Antignac C., et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002, 13(1):65-74.
10. Asano T., Niimura F., Pastan I., Fogo A.B., Ichikawa I., Matsusaka T. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005, 16(8):2257-2262.
11. Bader B.L., Smyth N., Nedbal S., Miosge N., Baranowsky A., Mokkapati S., et al. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol 2005, 25(15):6846-6856.
12. Bariety J., Mandet C., Hill G.S., Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006, 17(10):2770-2780.
13. Bieritz B., Spessotto P., Colombatti A., Jahn A., Prols F., Hartner A. Role of alpha8 integrin in mesangial cell adhesion, migration, and proliferation. Kidney Int 2003, 64(1):119-127.
14. Bjarnegård M., Enge M., Norlin J., Gustafsdottir S., Fredriksson S., Abramsson A., et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004, 131(8):1847-1857.
15. Blasutig I.M., New L.A., Thanabalasuriar A., Dayarathna T.K., Goudreault M., Quaggin S.E., et al. Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization. Mol Cell Biol 2008, 28(6):2035-2046.
16. Blouch K., Deen W.M., Fauvel J.P., Bialek J., Derby G., Myers B.D. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans. Am J Physiol 1997, 273(3 Pt 2):F430-7.
17. Bolton G.R., Deen W.M., Daniels B.S. Assessment of the charge selectivity of glomerular basement membrane using Ficoll sulfate. Am J Physiol 1998, 274(5 Pt 2):F889-96.
18. Borza C.M., Su Y., Chen X., Yu L., Mont S., Chetyrkin S., et al. Inhibition of integrin α2β1 ameliorates glomerular injury. J Am Soc Nephrol 2012, 23(6):1027-1038.
19. Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000, 24(4):349-354.
20. Boyer O., Nevo F., Plaisier E., Funalot B., Gribouval O., Benoit G., et al. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N Engl J Med 2011, 365(25):2377-2388.
21. Brenner B.M., Baylis C., Deen W.M. Transport of molecules across renal glomerular capillaries. Physiol Rev 1976, 56(3):502-534.
22. Brenner B.M., Bohrer M.P., Baylis C., Deen W.M. Determinants of glomerular permselectivity: insights derived from observations in vivo. Kidney Int 1977, 12(4):229-237.
23. Budde K., Becker T., Arns W., Sommerer C., Reinke P., Eisenberger U., et al. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de novo kidney transplants: an open-label, randomised, controlled trial. Lancet 2011, 377(9768):837-847.
24. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60(3):509-520.
25. Caricasole A., Duarte A., Larsson S.H., Hastie N.D., Little M., Holmes G., et al. RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA 1996, 93(15):7562-7566.
26. Caulfield J.P., Farquhar M.G. The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol 1974, 63(3):883-903.
27. Caulfield J.P., Farquhar M.G. Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci USA 1976, 73(5):1646-1650.
28. Chang R.L., Deen W.M., Robertson C.R., Brenner B.M. Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int 1975, 8(4):212-218.
29. Chang R.L., Ueki I.F., Troy J.L., Deen W.M., Robertson C.R., Brenner B.M. Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J 1975, 15(9):887-906.
30. Chau Y.-Y., Brownstein D., Mjoseng H., Lee W.-C., Buza-Vidas N., Nerlov C., et al. Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1. PLoS Genet 2011, 7(12):e1002404.
31. Chen H., Lun Y., Ovchinnikov D., Kokubo H., Oberg K.C., Pepicelli C.V., et al. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human Nail Patella syndrome. Nat Genet 1998, 19(1):51-55.
32. Chen L., Al-Awqati Q. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol Renal Physiol 2005, 288(5):F939-52.
33. Chen S., Wassenhove-McCarthy D.J., Yamaguchi Y., Holzman L.B., van Kuppevelt T.H., Jenniskens G.J., et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 2008, 74(3):289-299.
34. Chen X., Moeckel G., Morrow J.D., Cosgrove D., Harris R.C., Fogo A.B., et al. Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 2004, 165(2):617-630.
35. Cheng H.-T., Kim M., Valerius M.T., Surendran K., Schuster-Gossler K., Gossler A., et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007, 134(4):801-811.
36. Cho E.A., Patterson L.T., Brookhiser W.T., Mah S., Kintner C., Dressler G.R. Differential expression and function of cadherin-6 during renal epithelium development. Development 1998, 125(5):803-812.
37. Ciani L., Patel A., Allen N.D., ffrench-Constant C. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003, 23(10):3575-3582.
38. Cinà D.P., Onay T., Paltoo A., Li C., Maezawa Y., De Arteaga J., et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol 2011, 23(3):412-420.
39. Clement L.C., Avila-Casado C., Macé C., Soria E., Bakker W.W., Kersten S., et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011, 17(1):117-122.
40. Colognato H., Yurchenco P.D. Form and function: the laminin family of heterotrimers. Dev Dyn 2000, 218(2):213-234.
41. Cosgrove D., Meehan D.T., Grunkemeyer J.A., Kornak J.M., Sayers R., Hunter W.J., et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev 1996, 10(23):2981-2992.
42. Courtoy P.J., Timpl R., Farquhar M.G. Comparative distribution of laminin, type IV collagen, and fibronectin in the rat glomerulus. J Histochem Cytochem 1982, 30(9):874-886.
43. Coward R.J.M., Welsh G.I., Yang J., Tasman C., Lennon R., Koziell A., et al. The human glomerular podocyte is a novel target for insulin action. Diabetes 2005, 54(11):3095-3102.
44. Crean J.K.G., Finlay D., Murphy M., Moss C., Godson C., Martin F., et al. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 2002, 277(46):44187-44194.
45. Cybulsky A.V., Bonventre J.V., Quigg R.J., Lieberthal W., Salant D.J. Cytosolic calcium and protein kinase C reduce complement-mediated glomerular epithelial injury. Kidney Int 1990, 38(5):803-811.
46. Dai C., Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004, 15(6):1402-1412.
47. Dai C., Stolz D.B., Bastacky S.I., St-Arnaud R., Wu C., Dedhar S., et al. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006, 17(8):2164-2175.
48. Dai C., Yang J., Bastacky S., Xia J., Li Y., Liu Y. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 2004, 15(10):2637-2647.
49. Dai S., Wang Z., Pan X., Wang W., Chen X., Ren H., et al. Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Nephrol Dial Transplant 2010, 25(3):824-835.
50. Dandapani S.V., Sugimoto H., Matthews B.D., Kolb R.J., Sinha S., Gerszten R.E., et al. Alpha-actinin-4 is required for normal podocyte adhesion. J Biol Chem 2007, 282(1):467-477.
51. Darisipudi M.N., Kulkarni O.P., Sayyed S.G., Ryu M., Migliorini A., Sagrinati C., et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol 2011, 179(1):116-124.
52. Davis B., Dei Cas A., Long D.A., White K.E., Hayward A., Ku C.-H., et al. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 2007, 18(8):2320-2329.
53. Denys P., Malvaux P., Van Den Berghe H., Tanghe W., Proesmans W. Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism. Arch Fr Pediatr 1967, 24(7):729-739.
54. Ding G., Zhang A., Huang S., Pan X., Zhen G., Chen R., et al. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Am J Physiol Renal Physiol 2007, 293(6):F1889-97.
55. Ding M., Cui S., Li C., Jothy S., Haase V., Steer B.M., et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006, 12(9):1081-1087.
56. Diomedi-Camassei F., Di Giandomenico S., Santorelli F.M., Caridi G., Piemonte F., Montini G., et al. COQ2 nephropathy: A newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 2007, 18(10):2773-2780.
57. Donoviel D.B., Freed D.D., Vogel H., Potter D.G., Hawkins E., Barrish J.P., et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to nephrin. Mol Cell Biol 2001, 21(14):4829-4836.
58. Doyonnas R., Kershaw D.B., Duhme C., Merkens H., Chelliah S., Graf T., et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 2001, 194(1):13-27.
59. Drash A., Sherman F., Hartmann W.H., Blizzard R.M. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1970, 76(4):585-593.
60. Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W., et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998, 19(1):47-50.
61. Drummond I.A., Rupprecht H.D., Rohwer-Nutter P., Lopez-Guisa J.M., Madden S.L., Rauscher F.J., et al. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol 1994, 14(6):3800-3809.
62. El-Aouni C., Herbach N., Blattner S.M., Henger A., Rastaldi M.P., Jarad G., et al. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J Am Soc Nephrol 2006, 17(5):1334-1344.
63. Elger M., Drenckhahn D., Nobiling R., Mundel P., Kriz W. Cultured rat mesangial cells contain smooth muscle alpha-actin not found in vivo. Am J Pathol 1993, 142(2):497-509.
64. Elger M., Sakai T., Kriz W. The vascular pole of the renal glomerulus of rat. Adv Anat Embryol Cell Biol 1998, 139:1-98.
65. Eremina V., Cui S., Gerber H., Ferrara N., Haigh J., Nagy A., et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006, 17(3):724-735.
66. Eremina V., Jefferson J.A., Kowalewska J., Hochster H., Haas M., Weisstuch J., et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008, 358(11):1129-1136.
67. Eremina V., Quaggin S.E. The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 2004, 13(1):9-15.
68. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111(5):707-716.
69. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998, 140(4):947-959.
70. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420(6916):629-635.
71. Farquhar M.G., Palade G.E. Functional evidence for the existence of a third cell type in the renal glomerulus: phagocytosis of filtration residues by a distinctive "third" cell. J Cell Biol 1962, 13(1):55-87.
72. Faul C., Donnelly M., Merscher-Gomez S., Chang Y.H., Franz S., Delfgaauw J., et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008, 14(9):931-938.
73. Fierlbeck W., Liu A., Coyle R., Ballermann B.J. Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. J Am Soc Nephrol 2003, 14(5):1349-1354.
74. Fischer E.G., Moore M.J., Lager D.J. Fabry disease: a morphologic study of 11 cases. Mod Pathol 2006, 19(10):1295-1301.
75. Floege J., Burg M., Hugo C., Gordon K.L., Van Goor H., Reidy M., et al. Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 1998, 9(5):792-801.
76. Foo S.S., Turner C.J., Adams S., Compagni A., Aubyn D., Kogata N., et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006, 124(1):161-173.
77. Fox J.W., Mayer U., Nischt R., Aumailley M., Reinhardt D., Wiedemann H., et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J 1991, 10(11):3137-3146.
78. Fries J.W., Sandstrom D.J., Meyer T.W., Rennke H.G. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989, 60(2):205-218.
79. Gagliardini E., Conti S., Benigni A., Remuzzi G., Remuzzi A. Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 2010, 21(12):2081-2089.
80. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002, 3(3):411-423.
81. Galeano B., Klootwijk R., Manoli I., Sun M., Ciccone C., Darvish D., et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 2007, 117(6):1585-1594.
82. Gbadegesin R.A., Lavin P.J., Hall G., Bartkowiak B., Homstad A., Jiang R., et al. Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney Int 2012, 81(1):94-99.
83. Genovese G., Friedman D.J., Ross M.D., Lecordier L., Uzureau P., Freedman B.I., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329(5993):841-845.
84. Gerety S.S., Anderson D.J. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 2002, 129(6):1397-1410.
85. Ghayur M.N., Krepinsky J.C., Janssen L.J. Contractility of the renal glomerulus and mesangial cells: lingering doubts and strategies for the future. Med Hypotheses Res 2008, 4(1):1-9.
86. Gibson I.W., Downie I., Downie T.T., Han S.W., More I.A., Lindop G.B. The parietal podocyte: a study of the vascular pole of the human glomerulus. Kidney Int 1992, 41(1):211-214.
87. Gibson M.A., Kumaratilake J.S., Cleary E.G. The protein components of the 12-nanometer microfibrils of elastic and nonelastic tissues. J Biol Chem 1989, 264(8):4590-4598.
88. Goldberg S., Harvey S.J., Cunningham J., Tryggvason K., Miner J.H. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol Dial Transplant 2009, 24(7):2044-2051.
89. Gould D.B., Phalan F.C., van Mil S.E., Sundberg J.P., Vahedi K., Massin P., et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006, 354(14):1489-1496.
90. Gödel M., Hartleben B., Herbach N., Liu S., Zschiedrich S., Lu S., et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011, 121(6):2197-2209.
91. Greka A., Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol 2012, 74:299-323.
92. Groffen A.J., Ruegg M.A., Dijkman H., van de Velden T.J., Buskens C.A., van den Born J., et al. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem 1998, 46(1):19-27.
93. Grouls S., Iglesias D.M., Wentzensen N., Moeller M.J., Bouchard M., Kemler R., et al. Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol 2012, 23(1):63-72.
94. Guertin D.A., Sabatini D.M. The pharmacology of mTOR inhibition. Sci Signal 2009, 2(67):pe24.
95. Guo G., Morrison D.J., Licht J.D., Quaggin S.E. WT1 activates a glomerular-specific enhancer identified from the human nephrin gene. J Am Soc Nephrol 2004, 15(11):2851-2856.
96. Guo J.-K., Menke A.L., Gubler M.-C., Clarke A.R., Harrison D., Hammes A., et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 2002, 11(6):651-659.
97. Guo L., Sanders P.W., Woods A., Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 2001, 159(5):1735-1742.
98. Gurevich F., Perazella M.A. Renal effects of anti-angiogenesis therapy: update for the internist. Am J Med 2009, 122(4):322-328.
99. Haber D.A., Sohn R.L., Buckler A.J., Pelletier J., Call K.M., Housman D.E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991, 88(21):9618-9622.
100. Haensly W.E., Lee J.C. Metaplasia of the parietal layer of Bowman's capsule: a histopathological survey of the human kidney. Histol Histopathol 1986, 1(4):363-367.
101. Hamano Y., Grunkemeyer J.A., Sudhakar A., Zeisberg M., Cosgrove D., Morello R., et al. Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 2002, 277(34):31154-31162.
102. Hammes A., Guo J.K., Lutsch G., Leheste J.R., Landrock D., Ziegler U., et al. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 2001, 106(3):319-329.
103. Hanson J., Gorman J., Reese J., Fraizer G. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 2007, 12:2279-2290.
104. Haraldsson B., Nyström J., Deen W.M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008, 88(2):451-487.
105. Harita Y., Kurihara H., Kosako H., Tezuka T., Sekine T., Igarashi T., et al. Neph1, a component of the kidney slit diaphragm, is tyrosine-phosphorylated by the Src family tyrosine kinase and modulates intracellular signaling by binding to Grb2. J Biol Chem 2008, 283(14):9177-9186.
106. Hartleben B., Gödel M., Meyer-Schwesinger C., Liu S., Ulrich T., Köbler S., et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010, 120(4):1084-1096.
107. Hartwig S., Ho J., Pandey P., Macisaac K., Taglienti M., Xiang M., et al. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development. Development 2010, 137(7):1189-1203.
108. Harvey S.J., Jarad G., Cunningham J., Rops A.L., van der Vlag J., Berden J.H., et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 2007, 171(1):139-152.
109. Has C., Spartà G., Kiritsi D., Weibel L., Moeller A., Vega-Warner V., et al. Integrin α3 mutations with kidney, lung, and skin disease. N Engl J Med 2012, 366(16):1508-1514.
110. Heeringa S.F., Chernin G., Chaki M., Zhou W., Sloan A.J., Ji Z., et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 2011, 121(5):2013-2024.
111. Henderson J.M., Alexander M.P., Pollak M.R. Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury. J Am Soc Nephrol 2009, 20(5):961-968.
112. Henger A., Huber T., Fischer K.G., Nitschke R., Mundel P., Schollmeyer P., et al. Angiotensin II increases the cytosolic calcium activity in rat podocytes in culture. Kidney Int 1997, 52(3):687-693.
113. Hinkes B., Wiggins R.C., Gbadegesin R., Vlangos C.N., Seelow D., Nürnberg G., et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006, 38(12):1397-1405.
114. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993, 91(4):1367-1373.
115. Hjalmarsson C., Johansson B.R., Haraldsson B. Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvasc Res 2004, 67(1):9-17.
116. Hohenstein B., Hugo C.P.M., Hausknecht B., Boehmer K.P., Riess R.H., Schmieder R.E. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant 2008, 23(4):1346-1354.
117. Holthöfer H., Ahola H., Solin M.L., Wang S., Palmen T., Luimula P., et al. Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol 1999, 155(5):1681-1687.
118. Hua H., Munk S., Whiteside C.I. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol 2003, 284(2):F303-12.
119. Hudson B.G., Tryggvason K., Sundaramoorthy M., Neilson E.G. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003, 348(25):2543-2556.
120. Hyink D.P., Tucker D.C.St, John P.L., Leardkamolkarn V., Accavitti M.A., Abrass C.K., et al. Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am J Physiol 1996, 270(5 Pt 2):F886-99.
121. Ichimura K., Stan R.V., Kurihara H., Sakai T. Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol 2008, 19(8):1463-1471.
122. Inoki K., Mori H., Wang J., Suzuki T., Hong S., Yoshida S., et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011, 121(6):2181-2196.
123. Inoue T., Yaoita E., Kurihara H., Shimizu F., Sakai T., Kobayashi T., et al. FAT is a component of glomerular slit diaphragms. Kidney Int 2001, 59(3):1003-1012.
124. Jacinto E., Loewith R., Schmidt A., Lin S., Rüegg M.A., Hall A., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004, 6(11):1122-1128.
125. -/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006, 116(8):2272-2279.
126. Jarad G., Pippin J.W., Shankland S.J., Kreidberg J.A., Miner J.H. Dystroglycan does not contribute significantly to kidney development or function, in health or after injury. Am J Physiol Renal Physiol 2011, 300(3):F811-20.
127. Jeansson M., Gawlik A., Anderson G., Li C., Kerjaschki D., Henkelman M., et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011, 121(6):2278-2289.
128. Jeansson M., Haraldsson B. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 2003, 14(7):1756-1765.
129. Jeansson M., Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006, 290(1):F111-6.
130. 2+ and RhoA activation. Exp Biol Med (Maywood) 2011, 236(2):184-193.
131. Jones N., Blasutig I.M., Eremina V., Ruston J.M., Bladt F., Li H., et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006, 440(7085):818-823.
132. Kamba T., McDonald D.M. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007, 96(12):1788-1795.
133. Kamba T., Tam B.Y.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006, 290(2):H560-76.
134. Kanasaki K., Kanda Y., Palmsten K., Tanjore H., Lee S.B., Lebleu V.S., et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol 2008, 313(2):584-593.
135. Kanwar Y.S., Linker A., Farquhar M.G. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 1980, 86(2):688-693.
136. Kanwar Y.S., Danesh F.R., Chugh S.S. Contribution of proteoglycans towards the integrated functions of renal glomerular capillaries: a historical perspective. Am J Pathol 2007, 171(1):9-13.
137. Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.Q., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000, 24(3):251-256.
138. Karamatic Crew V., Burton N., Kagan A., Green C.A., Levene C., Flinter F., et al. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 2004, 104(8):2217-2223.
139. Kashtan C.E. Alport syndromes: phenotypic heterogeneity of progressive hereditary nephritis. Pediatr Nephrol 2000, 14(6):502-512.
140. Kerjaschki D. Polycation-induced dislocation of slit diaphragms and formation of cell junctions in rat kidney glomeruli: the effects of low temperature, divalent cations, colchicine, and cytochalasin B. Lab Invest 1978, 39(5):430-440.
141. Kerjaschki D., Farquhar M.G. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983, 157(2):667-686.
142. Kerjaschki D., Ojha P.P., Susani M., Horvat R., Binder S., Hovorka A., et al. A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol 1989, 134(2):481-489.
143. Kestilä M., Lenkkeri U., Männikkö M., Lamerdin J., McCready P., Putaala H., et al. Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1(4):575-582.
144. Kim J.M., Wu H., Green G., Winkler C.A., Kopp J.B., Miner J.H., et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003, 300(5623):1298-1300.
145. Kobayashi N., Mundel P. A role of microtubules during the formation of cell processes in neuronal and non-neuronal cells. Cell Tissue Res 1998, 291(2):163-174.
146. Kolatsi-Joannou M., Li X.Z., Suda T., Yuan H.T., Woolf A.S. Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Dev Dyn 2001, 222(1):120-126.
147. Kreidberg J.A. Functions of alpha3beta1 integrin. Curr Opin Cell Biol 2000, 12(5):548-553.
148. Kreidberg J.A., Donovan M.J., Goldstein S.L., Rennke H., Shepherd K., Jones R.C., et al. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 1996, 122(11):3537-3547.
149. Kreidberg J.A., Sariola H., Loring J.M., Maeda M., Pelletier J., Housman D., et al. WT-1 is required for early kidney development. Cell 1993, 74(4):679-691.
150. Kreidberg J.A., Symons J.M. Integrins in kidney development, function, and disease. Am J Physiol Renal Physiol 2000, 279(2):F233-42.
151. Kretzler M., Teixeira V.P., Unschuld P.G., Cohen C.D., Wanke R., Edenhofer I., et al. Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J 2001, 15(10):1843-1845.
152. Kriz W., Elger M., Mundel P., Lemley K.V. Structure-stabilizing forces in the glomerular tuft. J Am Soc Nephrol 1995, 5(10):1731-1739.
153. Kurihara H., Anderson J.M., Kerjaschki D., Farquhar M.G. The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1. Am J Pathol 1992, 141(4):805-816.
154. Kühn K. Basement membrane (type IV) collagen. Matrix Biol 1995, 14(6):439-445.
155. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149(2):274-293.
156. Le Hir M., Keller C., Eschmann V., Hähnel B., Hosser H., Kriz W. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2001, 12(10):2060-2071.
157. Le Roux S., Pepper R.J., Dufay A., Néel M., Meffray E., Lamandé N., et al. Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 2012, 23(1):155-164.
158. Lea P.J., Silverman M., Hegele R., Hollenberg M.J. Tridimensional ultrastructure of glomerular capillary endothelium revealed by high-resolution scanning electron microscopy. Microvasc Res 1989, 38(3):296-308.
159. Lee S., Kim W., Kim D.H., Moon S.-O., Jung Y.J., Lee A.S., et al. Protective effect of COMP-angiopoietin-1 on cyclosporine-induced renal injury in mice. Nephrol Dial Transplant 2008, 23(9):2784-2794.
160. Lenkkeri U., Männikkö M., McCready P., Lamerdin J., Gribouval O., Niaudet P.M., et al. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999, 64(1):51-61.
161. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994, 8(16):1875-1887.
162. Levine R.J., Maynard S.E., Qian C., Lim K.-H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350(7):672-683.
163. Li C., Ruotsalainen V., Tryggvason K., Shaw A.S., Miner J.H. CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol 2000, 279(4):F785-92.
164. Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997, 16(3):243-251.
165. Lindahl P., Hellström M., Kalén M., Karlsson L., Pekny M., Pekna M., et al. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998, 125(17):3313-3322.
166. Lindblom P., Gerhardt H., Liebner S., Abramsson A., Enge M., Hellstrom M., et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003, 17(15):1835-1840.
167. Liu A., Dardik A., Ballermann B.J. Neutralizing TGF-beta1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation 1. Kidney Int 1999, 56(4):1334-1348.
168. Liu G., Kaw B., Kurfis J., Rahmanuddin S., Kanwar Y.S., Chugh S.S. Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest 2003, 112(2):209-221.
169. Lu W., Phillips C.L., Killen P.D., Hlaing T., Harrison W.R., Elder F.F., et al. Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. Genomics 1999, 61(2):113-124.
170. Lund U., Rippe A., Venturoli D., Tenstad O., Grubb A., Rippe B. Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol 2003, 284(6):F1226-34.
171. Ma H., Togawa A., Soda K., Zhang J., Lee S., Ma M., et al. Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol 2010, 21(7):1145-1156.
172. Madri J.A., Roll F.J., Furthmayr H., Foidart J.M. Ultrastructural localization of fibronectin and laminin in the basement membranes of the murine kidney. J Cell Biol 1980, 86(2):682-687.
173. Maharaj A.S.R., Walshe T.E., Saint-Geniez M., Venkatesha S., Maldonado A.E., Himes N.C., et al. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 2008, 205(2):491-501.
174. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277(5322):55-60.
175. Makino H., Kashihara N., Sugiyama H., Kanao K., Sekikawa T., Shikata K., et al. Phenotypic changes of the mesangium in diabetic nephropathy. J Diabetes Complicat 1995, 9(4):282-284.
176. Marshall C.B., Shankland S.J. Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 2006, 102(2):e39-48.
177. Martinez-Hernandez A., Chung A.E. The ultrastructural localization of two basement membrane components: entactin and laminin in rat tissues. J Histochem Cytochem 1984, 32(3):289-298.
178. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998, 140(3):647-657.
179. Maynard S.E., Min J.-Y., Merchan J., Lim K.-H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111(5):649-658.
180. Mbassa G., Elger M., Kriz W. The ultrastructural organization of the basement membrane of Bowman's capsule in the rat renal corpuscle. Cell Tissue Res 1988, 253(1):151-163.
181. McCright B., Gao X., Shen L., Lozier J., Lan Y., Maguire M., et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128(4):491-502.
182. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006, 79(1):169-173.
183. Mele C., Iatropoulos P., Donadelli R., Calabria A., Maranta R., Cassis P., et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med 2011, 365(4):295-306.
184. Menke A.L., IJpenberg A., Fleming S., Ross A., Medine C.N., Patek C.E., et al. The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis. J Pathol 2003, 200(5):667-674.
185. Miner J.H., Li C. Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev Biol 2000, 217(2):278-289.
186. Miner J.H., Sanes J.R. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome. J Cell Biol 1996, 135(5):1403-1413.
187. Miner J.H. Building the glomerulus: a matricentric view. J Am Soc Nephrol 2005, 16(4):857-861.
188. Miner J.H. Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane. Organogenesis 2011, 7(2):75-82.
189. Miner J.H. The glomerular basement membrane. Exp Cell Res 2012, 318(9):973-978.
190. Miner J.H. Life without nephrin: it's for the birds. J Am Soc Nephrol 2012, 23(3):369-371.
191. Miner J.H., Morello R., Andrews K.L., Li C., Antignac C., Shaw A.S., et al. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J Clin Invest 2002, 109(8):1065-1072.
192. Miner J.H., Yurchenco P.D. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004, 20:255-284.
193. Moeller M.J., Soofi A., Hartmann I., Le Hir M., Wiggins R., Kriz W., et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004, 15(1):61-67.
194. Moore A.W., McInnes L., Kreidberg J., Hastie N.D., Schedl A. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999, 126(9):1845-1857.
195. Muchitsch E., Pichler L., Schwarz H.P., Ulrich W. Effects of human alpha-1-acid glycoprotein on aminonucleoside-induced minimal change nephrosis in rats. Nephron 1999, 81(2):194-199.
196. Mundel P., Kriz W. Structure and function of podocytes: an update. Anat Embryol 1995, 192(5):385-397.
197. Murakami T., Miyoshi M., Fujita T. Glomerular vessels of the rat kidney with special reference to double efferent arterioles. A scanning electron microscope study of corrosion casts. Arch Histol Jpn 1971, 33(3):179-198.
198. Murea M., Park J.-K., Sharma S., Kato H., Gruenwald A., Niranjan T., et al. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 2010, 78(5):514-522.
199. Murshed M., Smyth N., Miosge N., Karolat J., Krieg T., Paulsson M., et al. The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol 2000, 20(18):7007-7012.
200. Nakagawa T., Sato W., Glushakova O., Heinig M., Clarke T., Campbell-Thompson M., et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007, 18(2):539-550.
201. Narita M., Young A.R.J., Arakawa S., Samarajiwa S.A., Nakashima T., Yoshida S., et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011, 332(6032):966-970.
202. Niranjan T., Bielesz B., Gruenwald A., Ponda M.P., Kopp J.B., Thomas D.B., et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008, 14(3):290-298.
203. Nishiuchi R., Sanzen N., Nada S., Sumida Y., Wada Y., Okada M., et al. Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci USA 2005, 102(6):1939-1944.
204. Noakes P.G., Miner J.H., Gautam M., Cunningham J.M., Sanes J.R., Merlie J.P. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet 1995, 10(4):400-406.
205. Noonan D.M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991, 266(34):22939-22947.
206. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997, 16(3):235-242.
207. Ohse T., Chang A.M., Pippin J.W., Jarad G., Hudkins K.L., Alpers C.E., et al. A new function for parietal epithelial cells: A second glomerular barrier. Am J Physiol Renal Physiol 2009, 297(6):F1566-74.
208. Okamoto K., Tokunaga K., Doi K., Fujita T., Suzuki H., Katoh T., et al. Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat Genet 2011, 43(5):459-463.
209. Oliver J., MacDowell M. Nephrons and kidneys: a quantitative study of developmental and evolutionary mammalian renal architectonics 1968, Hoeber Medical Division, Harper & Row, New York.
210. Osterby R. Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Diabetologia 1972, 8(2):84-92.
211. Ozaltin F., Ibsirlioglu T., Taskiran E.Z., Baydar D.E., Kaymaz F., Buyukcelik M., et al. Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am J Hum Genet 2011, 89(1):139-147.
212. Pala L., Cresci B., Manuelli C., Maggi E., Yamaguchi Y.F., Cappugi P., et al. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: biological effects and advanced glycosilation end products modulation. Microvasc Res 2005, 70(3):179-188.
213. Palmer R.E., Kotsianti A., Cadman B., Boyd T., Gerald W., Haber D.A. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol 2001, 11(22):1805-1809.
214. Pelletier J., Bruening W., Kashtan C.E., Mauer S.M., Manivel J.C., Striegel J.E., et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67(2):437-447.
215. Peter K. Untersuchungen über bau und entwickelung der niere 1909, Gustav Fischer, Jena.
216. Petruzziello-Pellegrini T.N., Yuen D.A., Page A.V., Patel S., Soltyk A.M., Matouk C.C., et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 2012, 122(2):759-776.
217. Pitera J.E., Woolf A.S., Gale N.W., Yancopoulos G.D., Yuan H.T. Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice. Am J Pathol 2004, 165(6):1895-1906.
218. Plaisier E., Gribouval O., Alamowitch S., Mougenot B., Prost C., Verpont M.C., et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007, 357(26):2687-2695.
219. Pozzi A., Jarad G., Moeckel G.W., Coffa S., Zhang X., Gewin L., et al. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol 2008, 316(2):288-301.
220. Pricci F., Pugliese G., Romano G., Romeo G., Locuratolo N., Pugliese F., et al. Insulin-like growth factors I and II stimulate extracellular matrix production in human glomerular mesangial cells. Comparison with transforming growth factor-beta. Endocrinology 1996, 137(3):879-885.
221. Pugliese G., Pricci F., Locuratolo N., Romeo G., Romano G., Giannini S., et al. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production. Diabetologia 1996, 39(7):775-784.
222. Putaala H., Soininen R., Kilpeläinen P., Wartiovaara J., Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001, 10(1):1-8.
223. Quaggin S.E., Schwartz L., Cui S., Igarashi P., Deimling J., Post M., et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999, 126(24):5771-5783.
224. Quaggin S.E., Vanden Heuvel G.B., Igarashi P. Pod-1, a mesoderm-specific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney. Mech Dev 1998, 71(1-2):37-48.
225. Quaggin S.E., Kreidberg J.A. Development of the renal glomerulus: good neighbors and good fences. Development 2008, 135(4):609-620.
226. Raats C.J., van den Born J., Bakker M.A., Oppers-Walgreen B., Pisa B.J., Dijkman H.B., et al. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 2000, 156(5):1749-1765.
227. Raftopoulou M., Hall A. Cell migration: rho GTPases lead the way. Dev Biol 2004, 265(1):23-32.
228. Rahilly M.A., Fleming S. Differential expression of integrin alpha chains by renal epithelial cells. J Pathol 1992, 167(3):327-334.
229. Regele H.M., Fillipovic E., Langer B., Poczewki H., Kraxberger I., Bittner R.E., et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000, 11(3):403-412.
230. Reiser J., Kriz W., Kretzler M., Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000, 11(1):1-8.
231. Reiser J., Polu K.R., Möller C.C., Kenlan P., Altintas M.M., Wei C. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005, 37(7):739-744.
232. Rennke H.G., Venkatachalam M.A. Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int 1977, 11(1):44-53.
233. Rheault M.N., Kren S.M., Thielen B.K., Mesa H.A., Crosson J.T., Thomas W., et al. Mouse model of X-linked Alport syndrome. J Am Soc Nephrol 2004, 15(6):1466-1474.
234. Robert B.St, John P.L., Abrahamson D.R. Direct visualization of renal vascular morphogenesis in Flk1 heterozygous mutant mice. Am J Physiol 1998, 275(1 Pt 2):F164-72.
235. Robert B.St, John P.L., Hyink D.P., Abrahamson D.R. Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 1996, 271(3 Pt 2):F744-53.
236. Rodewald R., Karnovsky M.J. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 1974, 60(2):423-433.
237. Rohr C., Prestel J., Heidet L., Hosser H., Kriz W., Johnson R.L., et al. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 2002, 109(8):1073-1082.
238. Roll F.J., Madri J.A., Albert J., Furthmayr H. Codistribution of collagen types IV and AB2 in basement membranes and mesangium of the kidney. An immunoferritin study of ultrathin frozen sections. J Cell Biol 1980, 85(3):597-616.
239. Roselli S., Heidet L., Sich M., Henger A., Kretzler M., Gubler M.-C., et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004, 24(2):550-560.
240. Rosenzweig L.J., Kanwar Y.S. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest 1982, 47(2):177-184.
241. Rostgaard J., Qvortrup K. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res 1997, 53(1):1-13.
242. Rostgaard J., Qvortrup K. Sieve plugs in fenestrae of glomerular capillaries - site of the filtration barrier?. Cells Tissues Organs (Print) 2002, 170(2-3):132-138.
243. Ruotsalainen V., Ljungberg P., Wartiovaara J., Lenkkeri U., Kestilä M., Jalanko H., et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 1999, 96(14):7962-7967.
244. Ryan G., Steele-Perkins V., Morris J.F., Rauscher F.J., Dressler G.R. Repression of Pax-2 by WT1 during normal kidney development. Development 1995, 121(3):867-875.
245. Sadl V., Jin F., Yu J., Cui S., Holmyard D., Quaggin S., et al. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol 2002, 249(1):16-29.
246. Sakai T., Kriz W. The structural relationship between mesangial cells and basement membrane of the renal glomerulus. Anat Embryol 1987, 176(3):373-386.
247. Salmon A.H.J., Neal C.R., Sage L.M., Glass C.A., Harper S.J., Bates D.O. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res 2009, 83(1):24-33.
248. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.-H., Hsu P.P., Bagley A.F., et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006, 22(2):159-168.
249. Satchell S.C., Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 2009, 296(5):F947-56.
250. Satchell S.C., Harper S.J., Tooke J.E., Kerjaschki D., Saleem M.A., Mathieson P.W. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002, 13(2):544-550.
251. Sayyed S.G., Hägele H., Kulkarni O.P., Endlich K., Segerer S., Eulberg D., et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009, 52(11):2445-2454.
252. Schaefer L., Grone H.J., Raslik I., Robenek H., Ugorcakova J., Budny S., et al. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 2000, 58(4):1557-1568.
253. Scharpfenecker M., Fiedler U., Reiss Y., Augustin H.G. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005, 118(Pt 4):771-780.
254. Schlondorff J., Del Camino D., Carrasquillo R., Lacey V., Pollak M.R. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am J Physiol, Cell Physiol 2009, 296(3):C558-69.
255. Schmieder S., Nagai M., Orlando R.A., Takeda T., Farquhar M.G. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol 2004, 15(9):2289-2298.
256. Schnabel E., Anderson J.M., Farquhar M.G. The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol 1990, 111(3):1255-1263.
257. Schnaper H.W., Hayashida T., Hubchak S.C., Poncelet A.-C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003, 284(2):F243-52.
258. Schordan S., Schordan E., Endlich K., Endlich N. AlphaV-integrins mediate the mechanoprotective action of osteopontin in podocytes. Am J Physiol Renal Physiol 2011, 300(1):F119-32.
259. Schumacher V.A., Schlötzer-Schrehardt U., Karumanchi S.A., Shi X., Zaia J., Jeruschke S. WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier. J Am Soc Nephrol 2011, 22(7):1286-1296.
260. Schwartz E., Goldfischer S., Coltoff-Schiller B., Blumenfeld O.O. Extracellular matrix microfibrils are composed of core proteins coated with fibronectin. J Histochem Cytochem 1985, 33(4):268-274.
261. Schwarz K., Simons M., Reiser J., Saleem M.A., Faul C., Kriz W., et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001, 108(11):1621-1629.
262. Schymeinsky J., Nedbal S., Miosge N., Pöschl E., Rao C., Beier D.R., et al. Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice. Mol Cell Biol 2002, 22(19):6820-6830.
263. Scott R.P., Hawley S.P., Ruston J., Du J., Brakebusch C., Jones N., et al. Podocyte-specific loss of Cdc42 leads to congenital nephropathy. J Am Soc Nephrol 2012, [epub ahead of print].
264. Seiler M.W., Rennke H.G., Venkatachalam M.A., Cotran R.S. Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest 1977, 36(1):48-61.
265. Sellin L., Huber T.B., Gerke P., Quack I., Pavenstädt H., Walz G. NEPH1 defines a novel family of podocin interacting proteins. FASEB J 2003, 17(1):115-117.
266. Serra A.L., Poster D., Kistler A.D., Krauer F., Raina S., Young J., et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 2010, 363(9):820-829.
267. Shannon M.B., Patton B.L., Harvey S.J., Miner J.H. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease. J Am Soc Nephrol 2006, 17(7):1913-1922.
268. Shih N.Y., Li J., Cotran R., Mundel P., Miner J.H., Shaw A.S. CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 2001, 159(6):2303-2308.
269. Shih N.Y., Li J., Karpitskii V., Nguyen A., Dustin M.L., Kanagawa O., et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999, 286(5438):312-315.
270. Smeets B., Kuppe C., Sicking E.-M., Fuss A., Jirak P., van Kuppevelt T.H., et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011, 22(7):1262-1274.
271. Smith H.W. The kidney 1951, Oxford University Press, USA.
272. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994, 8(16):1888-1896.
273. St John P.L., Abrahamson D.R. Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains. Kidney Int 2001, 60(3):1037-1046.
274. Steffes M.W., Barbosa J., Basgen J.M., Sutherland D.E., Najarian J.S., Mauer S.M. Quantitative glomerular morphology of the normal human kidney. Lab Invest 1983, 49(1):82-86.
275. Sterk L.M.T., Geuijen C.A.W., van den Berg J.G., Claessen N., Weening J.J., Sonnenberg A. Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo. J Cell Sci 2002, 115(Pt 6):1161-1173.
276. Sterzel R.B., Hartner A., Schlotzer-Schrehardt U., Voit S., Hausknecht B., Doliana R., et al. Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int 2000, 58(4):1588-1602.
277. Stow J.L., Sawada H., Farquhar M.G. Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 1985, 82(10):3296-3300.
278. Suh J.H., Jarad G., VanDeVoorde R.G., Miner J.H. Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome. Proc Natl Acad Sci USA 2011, 108(37):15348-15353.
279. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87(7):1171-1180.
280. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393(6685):591-594.
281. Takabatake Y., Sugiyama T., Kohara H., Matsusaka T., Kurihara H., Koni P.A., et al. The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J Am Soc Nephrol 2009, 20(8):1714-1723.
282. Takahashi T., Takahashi K., Gerety S., Wang H., Anderson D.J., Daniel T.O. Temporally compartmentalized expression of ephrin-B2 during renal glomerular development. J Am Soc Nephrol 2001, 12(12):2673-2682.
283. Takeda T., McQuistan T., Orlando R.A., Farquhar M.G. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 2001, 108(2):289-301.
284. Takemoto M., He L., Norlin J., Patrakka J., Xiao Z., Petrova T., et al. Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J 2006, 25(5):1160-1174.
285. Teixeira V., de P.C., Blattner S.M., Li M., Anders H.-J., Cohen C.D., Edenhofer I., et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005, 67(2):514-523.
286. Tessari P., Cecchet D., Cosma A., Vettore M., Coracina A., Millioni R., et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 2010, 59(9):2152-2159.
287. Tian D., Jacobo S.M.P., Billing D., Rozkalne A., Gage S.D., Anagnostou T., et al. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 2010, 3(145):ra77.
288. Trachtman H. Nitric oxide and glomerulonephritis. Semin Nephrol 2004, 24(4):324-332.
289. Tryggvason K., Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001, 10(4):543-549.
290. Tryggvason K., Patrakka J., Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006, 354(13):1387-1401.
291. Utriainen A., Sormunen R., Kettunen M., Carvalhaes L.S., Sajanti E., Eklund L., et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum Mol Genet 2004, 13(18):2089-2099.
292. Venkatesha S., Toporsian M., Lam C., Hanai J.-I., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12(6):642-649.
293. Vogelmann S.U., Nelson W.J., Myers B.D., Lemley K.V. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003, 285(1):F40-8.
294. Vollenbröker B., George B., Wolfgart M., Saleem M.A., Pavenstädt H., Weide T. mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes. Am J Physiol Renal Physiol 2009, 296(2):F418-26.
295. Voskarides K., Damianou L., Neocleous V., Zouvani I., Christodoulidou S., Hadjiconstantinou V., et al. COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol 2007, 18(11):3004-3016.
296. Völker L.A., Petry M., Abdelsabour-Khalaf M., Schweizer H., Yusuf F., Busch T., et al. Comparative analysis of Neph gene expression in mouse and chicken development. Histochem Cell Biol 2012, 137(3):355-366.
297. Wada J., Makino H., Kanwar Y.S. Gene expression and identification of gene therapy targets in diabetic nephropathy. Kidney Int 2002, 61(1 Suppl):S73-8.
298. Wagner N., Wagner K.-D., Xing Y., Scholz H., Schedl A. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. J Am Soc Nephrol 2004, 15(12):3044-3051.
299. Wang H.U., Anderson D.J. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 1997, 18(3):383-396.
300. Waters A.M., Wu M.Y.J., Onay T., Scutaru J., Liu J., Lobe C.G., et al. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008, 19(6):1139-1157.
301. Wei C., Hindi El S., Li J., Fornoni A., Goes N., Sageshima J., et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011, 17(8):952-960.
302. Wei C., Möller C.C., Altintas M.M., Li J., Schwarz K., Zacchigna S., et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008, 14(1):55-63.
303. Weins A., Schlondorff J.S., Nakamura F., Denker B.M., Hartwig J.H., Stossel T.P., et al. Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proc Natl Acad Sci USA 2007, 104(41):16080-16085.
304. Welsh G.I., Hale L.J., Eremina V., Jeansson M., Maezawa Y., Lennon R., et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 2010, 12(4):329-340.
305. Wendel M., Knels L., Kummer W., Koch T. Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney. J Histochem Cytochem 2006, 54(11):1193-1203.
306. Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T., Hawkins A.F., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005, 308(5729):1801-1804.
307. Wnuk M., Hlushchuk R., Janot M., Tuffin G., Martiny-Baron G., Holzer P., et al. Podocyte EphB4 signaling helps recovery from glomerular injury. Kidney Int 2012, 81(12):1212-1225.
308. Woolf A.S. Angiopoietins: Vascular growth factors looking for roles in glomeruli. Curr Opin Nephrol Hypertens 2010, 19(1):20-25.
309. Wu C., Dedhar S. Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001, 155(4):505-510.
310. Yamagishi S.-I., Matsui T. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy: friend or foe?. Pharmacol Res 2011, 64(3):187-194.
311. Yang Y., Jeanpierre C., Dressler G.R., Lacoste M., Niaudet P., Gubler M.C. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 1999, 154(1):181-192.
312. Yang Y., Guo L., Blattner S.M., Mundel P., Kretzler M., Wu C. Formation and phosphorylation of the PINCH-1-integrin linked kinase-alpha-parvin complex are important for regulation of renal glomerular podocyte adhesion, architecture, and survival. J Am Soc Nephrol 2005, 16(7):1966-1976.
313. Yaoita E., Kurihara H., Yoshida Y., Inoue T., Matsuki A., Sakai T., et al. Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney. Kidney Int 2005, 68(2):542-551.
314. Yauch R.L., Kazarov A.R., Desai B., Lee R.T., Hemler M.E. Direct extracellular contact between integrin alpha(3)beta(1) and TM4SF protein CD151. J Biol Chem 2000, 275(13):9230-9238.
315. Ye M., Wysocki J., William J., Soler M.J., Cokic I., Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: Implications for albuminuria in diabetes. J Am Soc Nephrol 2006, 17(11):3067-3075.
316. Yu D., Petermann A., Kunter U., Rong S., Shankland S.J., Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005, 16(6):1733-1741.
317. Yu L., McPhee C.K., Zheng L., Mardones G.A., Rong Y., Peng J., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465(7300):942-946.
318. Yuan H.T., Suri C., Landon D.N., Yancopoulos G.D., Woolf A.S. Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature. J Am Soc Nephrol 2000, 11(6):1055-1066.
319. Yuan H.T., Suri C., Yancopoulos G.D., Woolf A.S. Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol 1999, 10(8):1722-1736.
320. Yuan H.T., Khankin E.V., Karumanchi S.A., Parikh S.M. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 2009, 29(8):2011-2022.
321. Zeng Z., Sarbassov D.D., Samudio I.J., Yee K.W.L., Munsell M.F., Ellen Jackson C., et al. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood 2007, 109(8):3509-3512.
322. Zenker M., Aigner T., Wendler O., Tralau T., Müntefering H., Fenski R., et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004, 13(21):2625-2632.
323. Zent R., Yan X., Su Y., Hudson B.G., Borza D.-B., Moeckel G.W. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. Kidney Int 2006, 70(3):460-470.
324. Zhao H.J., Wang S., Cheng H., Zhang M.-Z., Takahashi T., Fogo A.B., et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006, 17(10):2664-2669.
325. Zhu L., Jiang R., Aoudjit L., Jones N., Takano T. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. J Am Soc Nephrol 2011, 22(9):1621-1630.
326. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12(1):21-35.